The future of cardiometabolic care is being built now. Come help shape it.
GLP-1s are the fastest-adopted drug class in history, however, the healthcare system wasn't built for them. The clinical breakthrough has happened and the harder challenge is now: turning a prescription into a sustained outcome across a fragmented ecosystem of drug makers, pharmacies, digital health programs, employers, and payers.
This exclusive event brings together senior leaders to go beyond the hype and into the hard questions: who closes the access gap, who owns engagement after the prescription is filled, and what does real ecosystem alignment actually look like?
This is a curated, invite-only event. Attendance is limited to 30 guests. RSVP today to reserve your spot.
